Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ukai

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Pharmacology, Biochemistry, and Behavior|March 1, 1994
NS-3, a TRH analog, reverses repeated ECS-induced deficits in water maze performance in the ratA Khan, H Lai, Y Ukai, et al.
Neuroscience Letters|June 19, 2001
Reversal by NS-7, a neuroprotective compound, of the decrease in transcription factor CREB mRNA expression in rat brain after permanent middle cerebral artery occlusionM Hirouchi, Y Itoh, Y Aoki, et al.
Brain Research|February 13, 2001
Cerebroprotective action of a Na+/Ca2+ channel blocker NS-7. II. Effect on the cerebral infarction, behavioral and cognitive impairments at the chronic stage of permanent middle cerebral artery occlusion in ratsM Tamura, Y Aoki, T Seto, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|July 1, 1988
Enhancement of salivary secretion by chronic anethole trithione treatmentY Ukai, N Taniguchi, K Takeshita, et al.
Pharmacology & Toxicology|June 1, 1996
Enhancement of brain noradrenaline and dopamine turnover by thyrotropin-releasing hormone and its analogue NS-3 in mice and ratsY Itoh, A Yamazaki, Y Ukai, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1997
Inhibitory effects of NS-21, a novel drug for urinary incontinence, and its active metabolite, RCC-36, on L-type calcium currents in isolated guinea pig detrusor smooth muscle cellsS Hayashi, T Natsukawa, Y Ukai, et al.
European Journal of Pharmacology|January 24, 1998
Na+ and high-voltage-activated Ca2+ channel blocking actions of NS-7, a novel neuroprotective agent, in NG108-15 cellsC Suma, S Hayashi, Y Ukai, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|October 1, 1984
Chronic anethole trithione treatment enhances the salivary secretion and increases the muscarinic acetylcholine receptors in the rat submaxillary glandY Ukai, N Taniguchi, K Takeshita, et al.
Journal of Neurochemistry|May 1, 1996
Protein kinases are involved in prolonged acetylcholine release from rat hippocampus induced by thyrotropin-releasing hormone analogue NS-3M Oka, Y Itoh, Y Ukai, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|August 1, 1996
[EEG studies on the analeptic effect of montirelin hydrate (NS-3), a TRH analog, in posterior hypothalamic area-lesioned rats]T Mushiroi, R Shibahara, Y Ukai, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Pharmacology, Biochemistry, and Behavior|March 1, 1994
NS-3, a TRH analog, reverses repeated ECS-induced deficits in water maze performance in the ratA Khan, H Lai, Y Ukai, et al.
Neuroscience Letters|June 19, 2001
Reversal by NS-7, a neuroprotective compound, of the decrease in transcription factor CREB mRNA expression in rat brain after permanent middle cerebral artery occlusionM Hirouchi, Y Itoh, Y Aoki, et al.
Brain Research|February 13, 2001
Cerebroprotective action of a Na+/Ca2+ channel blocker NS-7. II. Effect on the cerebral infarction, behavioral and cognitive impairments at the chronic stage of permanent middle cerebral artery occlusion in ratsM Tamura, Y Aoki, T Seto, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|July 1, 1988
Enhancement of salivary secretion by chronic anethole trithione treatmentY Ukai, N Taniguchi, K Takeshita, et al.
Pharmacology & Toxicology|June 1, 1996
Enhancement of brain noradrenaline and dopamine turnover by thyrotropin-releasing hormone and its analogue NS-3 in mice and ratsY Itoh, A Yamazaki, Y Ukai, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1997
Inhibitory effects of NS-21, a novel drug for urinary incontinence, and its active metabolite, RCC-36, on L-type calcium currents in isolated guinea pig detrusor smooth muscle cellsS Hayashi, T Natsukawa, Y Ukai, et al.
European Journal of Pharmacology|January 24, 1998
Na+ and high-voltage-activated Ca2+ channel blocking actions of NS-7, a novel neuroprotective agent, in NG108-15 cellsC Suma, S Hayashi, Y Ukai, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|October 1, 1984
Chronic anethole trithione treatment enhances the salivary secretion and increases the muscarinic acetylcholine receptors in the rat submaxillary glandY Ukai, N Taniguchi, K Takeshita, et al.
Journal of Neurochemistry|May 1, 1996
Protein kinases are involved in prolonged acetylcholine release from rat hippocampus induced by thyrotropin-releasing hormone analogue NS-3M Oka, Y Itoh, Y Ukai, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|August 1, 1996
[EEG studies on the analeptic effect of montirelin hydrate (NS-3), a TRH analog, in posterior hypothalamic area-lesioned rats]T Mushiroi, R Shibahara, Y Ukai, et al.
Pageof 9